Inotiv, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NOTV research report →
About the company
Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally. The company operates through two segments, Discovery and Safety Assessment (DSA) and Research Models and Services (RMS).
- CEO
- Robert W. Leasure
- IPO
- 1997
- Employees
- 2,027
- HQ
- West Lafayette, IN, US
Price Chart
- Market Cap
- $2.79M
- P/E
- -0.00
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- 46.38
- Div Yield
- 0.00%
- Gross Margin
- 14.70%
- Op Margin
- -8.87%
- Net Margin
- -17.14%
- ROE
- -74.67%
- ROIC
- -6.25%
- Revenue
- $513.02M · 4.54%
- Net Income
- $-68,625,000 · 36.72%
- EPS
- $-2.11 · 49.64%
- Op Income
- $-30,902,000
- FCF YoY
- 7.02%
- 52W High
- $2.44
- 52W Low
- $0.02
- 50D MA
- $0.24
- 200D MA
- $0.64
- Beta
- 4.08
- Avg Volume
- 19.82M
Get TickerSpark's AI analysis on NOTV
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 18, 26 | Taylor Beth A. | other | 5,864 |
| Jun 18, 26 | Sagartz John E | other | 6,071 |
| Jun 18, 26 | Hardy Adrian | other | 5,371 |
| Jun 18, 26 | Freeman Jeffrey Brennan | other | 5,855 |
| Jun 18, 26 | Castetter Andrea | other | 5,800 |
| Jun 18, 26 | Beattie John Gregory | other | 5,769 |
Our NOTV coverage
Recent articles, reports, and earnings notes.
No research on NOTV yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate NOTV report →Similar companies
Peers in the same neighborhood.